作者
Writing Committee Members, Elliott M Antman, Daniel T Anbe, Paul Wayne Armstrong, Eric R Bates, Lee A Green, Mary Hand, Judith S Hochman, Harlan M Krumholz, Frederick G Kushner, Gervasio A Lamas, Charles J Mullany, Joseph P Ornato, David L Pearle, Michael A Sloan, Sidney C Smith Jr, Elliott M Antman, Sidney C Smith Jr, Joseph S Alpert, Jeffrey L Anderson, David P Faxon, Valentin Fuster, Raymond J Gibbons, Gabriel Gregoratos, Jonathan L Halperin, Loren F Hiratzka, Sharon Ann Hunt, Alice K Jacobs, Joseph P Ornato
发表日期
2004/8/3
期刊
Circulation
卷号
110
期号
5
页码范围
588-636
出版商
Lippincott Williams & Wilkins
简介
D. Medication Assessment............................................ 610 1. Beta Blockers..................................................... 609 2. Nitroglycerin...................................................... 610 3. Inhibition of the Renin-Angiotensin-Aldosterone System.......................................... 610 4. Antiplatelets....................................................... 611 5. Antithrombotics................................................. 611 6. Oxygen............................................................... 611 E. Estimation of Infarct Size.................................... 611 1. Electrocardiographic Techniques...................... 611 2. Cardiac Biomarker Methods............................. 611 3. Radionuclide Imaging........................................ 611 4. Echocardiography.............................................. 611 5. Magnetic Resonance Imaging........................... 611 F. Hemodynamic Disturbances................................. 611 1. Hemodynamic Assessment................................ 611 2. Hypotension....................................................... 612 3. Low-Output State............................................... 612 4 …
引用总数
2004200520062007200820092010201120122013201420152016201720182019202020212022202320243934256471683898794986178164752341638526022119218919317010246
学术搜索中的文章